Abstract:BackgroundHematopoietic stem cell (HSC) transplantation is an effective treatment strategy for many types of diseases. Peripheral blood (PB) is the most commonly used source of bone marrow (BM)-derived stem cells for current HSC transplantation. However, PB usually contains very few HSCs under normal conditions, as these cells are normally retained within the BM. This retention depends on the interaction between the CXC chemokine receptor 4 (CXCR4) expressed on the HSCs and its natural chemokine ligand, stromal cell-derived factor (SDF)-1 alpha (also named CXCL12) present in the BM stromal microenvironment. In clinical practice, blocking this interaction with a CXCR4 antagonist can induce the rapid mobilization of HSCs from the BM into the PB.MethodsC3H/HEJ, DBA/2, CD45.1(+), and CD45.2(+) mice and monkeys were employed in colony-forming unit (CFU) assays, flow cytometry assays, and competitive/noncompetitive transplantation assays, to assess the short-term mobilization efficacy of HF51116 and the long-term repopulating (LTR) ability of HSCs. Kinetics of different blood cells and the concentration of HF51116 in PB were also explored by blood routine examinations and pharmacokinetic assays.ResultsIn this paper, we report that a novel small molecule CXCR4 antagonist, HF51116, which was designed and synthesized by our laboratory, can rapidly and potently mobilize HSCs from BM to PB in mice and monkeys. HF51116 not only mobilized HSCs when used alone but also synergized with the mobilizing effects of granulocyte colony-stimulating factor (G-CSF) after co-administration. Following mobilization by HF51116 and G-CSF, the long-term repopulating (LTR) and self-renewing HSCs were sufficiently engrafted in primary and secondary lethally irradiated mice and were able to rescue and support long-term mouse survival. In monkeys, HF51116 exhibited strong HSC mobilization activity and quickly reached the highest in vivo blood drug concentration.ConclusionsThese results demonstrate that HF51116 is a new promising stem cell mobilizer which specifically targets CXCR4 and merits further preclinical and clinical studies.

Abstract 12148: CXCR4 Mediated Bone Marrow Progenitor Cell Maintenance and Mobilization Are Modulated by C-Kit Activity

CXCR4-Mediated Bone Marrow Progenitor Cell Maintenance and Mobilization Are Modulated by C-Kit Activity

A Critical Role of Src Family Kinase in SDF-1/CXCR4-mediated Bone-Marrow Progenitor Cell Recruitment to the Ischemic Heart

CXCR4 Protects Bone Marrow-Derived Endothelial Progenitor Cells Against Hypoxia Through the PI3K/Akt Signaling Pathway

Co-transplantation of Hematopoietic Stem Cells and Cxcr4 Gene-Transduced Mesenchymal Stem Cells Promotes Hematopoiesis

Cdc42 Inhibitor ML141 Enhances G-CSF-induced Hematopoietic Stem and Progenitor Cell Mobilization.

Transmyocardial Revascularization Enhances Bone Marrow Stem Cell Engraftment in Infarcted Hearts Through SCF-C-kit and SDF-1-CXCR4 Signaling Axes

CXCR4 Antagonist AMD3100 Promotes Mesenchymal Stem Cell Mobilization in Rats Preconditioned with the Hypoxia-Mimicking Agent Cobalt Chloride

Mobilization of Bone Marrow-Derived Nkx2-5(+) Cardiac Progenitor Cells under Condition of Acute Myocardial Ischemia.

CXCR2 modulates bone marrow vascular repair and haematopoietic recovery post-transplant.

Regulation of C-Kit+ Progenitor Cells by Stromal Cell Derived Factor-1Α in Adult Murine Heart.

Notch-Rbp-J Signaling Regulates The Mobilization And Function Of Endothelial Progenitor Cells By Dynamic Modulation Of Cxcr4 Expression In Mice

Experimental study on the mobilization effects and mechanisms of granulocyte colony-stimulating factor and stem cell factor to bone marrow mononuclear cells

Mobilization Efficiency of Granulocyte Colony-stimulating Factor and Stem Cell Factor to Bone Marrow Mononuclear Cells and Mechanisms

C-Kit-Mediated Functional Positioning of Stem Cells to Their Niches is Essential for Maintenance and Regeneration of Adult Hematopoiesis

Epigenetic Regulation of Cardiac Progenitor Cells Marker C-Kit by Stromal Cell Derived Factor-1α

A Novel Small Molecule CXCR4 Antagonist Potently Mobilizes Hematopoietic Stem Cells in Mice and Monkeys

Selective Enhancement of Donor Hematopoietic Cell Engraftment by the CXCR4 Antagonist AMD3100 in a Mouse Transplantation Model

Functional consequences of perturbed CXCL12 signal processing: analyses of immature hematopoiesis in GRK6-deficient mice

Genetic Lineage Tracing Analysis of C-Kit(+) Stem/progenitor Cells Revealed a Contribution to Vascular Injury-Induced Neointimal Lesions

AMD3100 Mobilizes Endothelial Progenitor Cells in Mice, but Inhibits Its Biological Functions by Blocking an Autocrine/Paracrine Regulatory Loop of Stromal Cell Derived Factor-1 in Vitro